BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32064528)

  • 1. Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo.
    Connelly JC; Cholewa-Waclaw J; Webb S; Steccanella V; Waclaw B; Bird A
    Nucleic Acids Res; 2020 Apr; 48(7):3542-3552. PubMed ID: 32064528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain.
    Lagger S; Connelly JC; Schweikert G; Webb S; Selfridge J; Ramsahoye BH; Yu M; He C; Sanguinetti G; Sowers LC; Walkinshaw MD; Bird A
    PLoS Genet; 2017 May; 13(5):e1006793. PubMed ID: 28498846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of MeCP2 Distribution on Non-CpG Methylated and Hydroxymethylated DNA.
    Sperlazza MJ; Bilinovich SM; Sinanan LM; Javier FR; Williams DC
    J Mol Biol; 2017 May; 429(10):1581-1594. PubMed ID: 28450074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.
    Lei M; Tempel W; Chen S; Liu K; Min J
    Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeCP2 binding to DNA depends upon hydration at methyl-CpG.
    Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD
    Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin.
    Hansen JC; Ghosh RP; Woodcock CL
    IUBMB Life; 2010 Oct; 62(10):732-8. PubMed ID: 21031501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2.
    Chhatbar K; Connelly J; Webb S; Kriaucionis S; Bird A
    Life Sci Alliance; 2022 Dec; 5(12):. PubMed ID: 36122935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
    Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique physical properties and interactions of the domains of methylated DNA binding protein 2.
    Ghosh RP; Nikitina T; Horowitz-Scherer RA; Gierasch LM; Uversky VN; Hite K; Hansen JC; Woodcock CL
    Biochemistry; 2010 May; 49(20):4395-410. PubMed ID: 20405910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical characterization of the basic cluster in the transcription repression domain of human MeCP2 with AT-rich DNA.
    Mushtaq AU; Lee Y; Hwang E; Bang JK; Hong E; Byun Y; Song JJ; Jeon YH
    Biochem Biophys Res Commun; 2018 Jan; 495(1):145-150. PubMed ID: 29101034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intervening domain from MeCP2 enhances the DNA affinity of the methyl binding domain and provides an independent DNA interaction site.
    Claveria-Gimeno R; Lanuza PM; Morales-Chueca I; Jorge-Torres OC; Vega S; Abian O; Esteller M; Velazquez-Campoy A
    Sci Rep; 2017 Jan; 7():41635. PubMed ID: 28139759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation.
    Ishibashi T; Thambirajah AA; Ausió J
    FEBS Lett; 2008 Apr; 582(7):1157-62. PubMed ID: 18339321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.
    Ghosh RP; Horowitz-Scherer RA; Nikitina T; Shlyakhtenko LS; Woodcock CL
    Mol Cell Biol; 2010 Oct; 30(19):4656-70. PubMed ID: 20679481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methyl CpG-binding protein 2 (MeCP2) inhibits the activity of methylated IL-6 promoter of HEK293 cells and its molecular mechanism].
    Hu K; Li Y; Cao X; Chen Y; Chen L; Jin L; Tan B; Yin H; Huang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):204-211. PubMed ID: 35365985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methyl-CpG-binding protein MeCP2 and neurological disease.
    Bird A
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-specific DNA binding by AT-hook motifs in MeCP2.
    Lyst MJ; Connelly J; Merusi C; Bird A
    FEBS Lett; 2016 Sep; 590(17):2927-33. PubMed ID: 27461740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain.
    Galvão TC; Thomas JO
    Nucleic Acids Res; 2005; 33(20):6603-9. PubMed ID: 16314321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.